Meniere's Disease

BASICS

DESCRIPTION
An inner ear (labyrinthine) disorder in which there is an increase in volume and pressure of the inner-most fluid of the inner ear (endolymph), resulting in recurrent attacks of hearing loss, tinnitus, vertigo, and fullness
  • Usually unilateral, but in 10-50% may later involve the second ear
  • Severity and frequency may diminish over the years, but with increasing loss of hearing. It is not a synonym for dizziness
  • System(s) affected: Nervous
  • Genetics: N/A
  • Incidence/Prevalence in USA:
    • No reliable figures are available to provide comprehensive numbers for incidence and prevalence by age and sex, but using incidence figures from a Swedish study conducted in 1973, it is estimated that the incidence of Ménière's disease in the US is 46 (new cases/100,000/year). No figures for sex and age are available, but the disease is relatively equal in males and females, and is extremely rare in children
    • Using extrapolation, the estimated prevalence is 1,150 (cases/100,000 population)
  • Predominant age: Usual age of onset 20-60
  • Predominant sex: Male = Female
SIGNS AND SYMPTOMS
  • Hearing loss - low frequency, fluctuating
  • Vertigo - spontaneous attacks, duration 20 minutes to several hours
  • Ear fullness
  • Occurs as attacks, with intervening remission
  • During severe attacks
    • Pallor
    • Sweating
    • Nausea and vomiting
    • Falling
    • Prostration
    • All symptoms aggravated by motion
    • Between attacks may experience motion-related imbalance without vertigo
CAUSES
  • Unknown. Best theory is inner ear response to variety of injuries (reduced middle ear pressure, allergy, endocrine disease, lipid disorders, vascular, viral, luetic)
  • Recent theory is intracranial compression of balance nerve by blood vessel
RISK FACTORS
  • Caucasian
  • Stress
  • Allergy
  • Increased salt intake
  • Noise

DIAGNOSIS

LABORATORY
  • Lab studies done to rule out other conditions
  • Serologic tests specific for Treponema pallidum - microhemagglutination (MHA), fluorescent treponemal antibody (FTA), Treponema immobilization test (TPI)
  • Thyroid studies
  • Lipid studies

Drugs that may alter lab results: Any medication that produces a significant degree of sedation is likely to affect vestibular testing and invalidate it
Disorders that may alter lab results: Many conditions may produce auditory and vestibular findings identical to those associated with Ménière's disease, making it a diagnosis of exclusion. A low frequency sensorineural hearing loss (nerve loss as opposed to conductive loss) is seen on audiometry, and a reduced caloric response on caloric testing is usual.

PATHOLOGICAL FINDINGS
Autopsy only. Shows dilation of inner ear fluid system (endolymph).
SPECIAL TESTS
  • Otoscopy with air pressure applied to the tympanic membrane
  • Auditory
    • Hearing test (audiometry using pure tone and speech) to show low frequency sensorineural [nerve] loss and impaired speech discrimination
    • Tuning fork test (Weber and Rinne) to confirm validity of audiometry
    • Auditory Brainstem Response audiometry (ABR) to rule out acoustic neuroma
  • Vestibular
    • Spontaneous nystagmus (rapid rhythmic eye motion) seen visually. Must avoid eye fixation by having patient use 40 diopter glasses for test
    • Caloric testing - electronystagmography (ENG) may show reduced caloric response. Can obtain reasonably comparable information with use of 0.8 cc ice water instilled in ear canal, then noting duration and frequency of resulting nystagmus with 40 diopter lenses in place. Reduced activity on either side is consistent with Ménière's diagnosis, but is not diagnostic
IMAGING
MRI to rule out acoustic tumor, which can produce identical symptoms and findings
DIAGNOSTIC PROCEDURES
N/A

TREATMENT

APPROPRIATE HEALTH CARE

Can usually be managed in outpatient setting. Inpatient for surgery.

GENERAL MEASURES
  • Medications are given primarily for symptomatic relief of vertigo and nausea. There is no medication available that influences the disease process
  • For attacks, bedrest with eyes closed and protection from falling. Attacks rarely last longer than four hours
  • Streptomycin therapy for bilateral Ménière's disease, when conventional management has failed. Streptomycin may be administered over a period of several days or weeks intentionally to damage the neuro-epithelium of the balance centers and reduce their function. Hearing must be carefully monitored during this time so that the treatment does not proceed to the point of damaging the hearing structures. This form of treatment should be administered only by an otolaryngologist and after careful patient education
SURGICAL MEASURES
  • Hearing good: Endolymphatic sac surgery, either (1) decompression or (2) drainage of endolymph into mastoid or subarachnoid space. Alternative procedure is to cut the vestibular nerve (intracranial procedure). A newer procedure involves placement of gentamicin through the tympanic membrane into the middle ear space
  • Hearing poor, but usable: Can do sac procedure, nerve section, or gentamicin instillation depending on quality of hearing. For poor hearing, can decompress cochlea (cochleocentesis), or perfuse cochlea with streptomycin
  • Hearing not useful: Destruction of inner ear (labyrinthectomy)
ACTIVITY
  • Limit activity during attacks
  • Between attacks patient may be fully active, but this may be limited by
    • Fear of impending attack
    • Unsteadiness following attacks
    • Ear fullness or tinnitus
    • Hearing loss in involved ear that may severely limit the patient's ability to perform work duties or to participate in social life
DIET

Limit total intake during attacks because of nausea. Otherwise diet is usually not a factor unless attacks are brought on by certain foods. A restricted salt diet may be useful in some cases.

PATIENT EDUCATION

Many otolaryngologists keep booklets on Ménière's disease as handouts. Ask your otolaryngology consultant for a supply.

FOLLOW UP

PREVENTION/AVOIDANCE
  • Reduce stress
  • Reduce salt intake
  • Don't smoke
  • Avoid significant noise exposure, or use ear protectors
  • Avoid use of ototoxic medications (aspirin, quinine, kanamycin, and many others)
POSSIBLE COMPLICATIONS
  • Failure to diagnose acoustic neuroma
  • Loss of hearing
  • Injury during attack
  • Inability to work
EXPECTED COURSE AND PROGNOSIS
  • Alternating attacks and remission
  • Over time the balance problem tends to resolve, but the hearing worsens
  • The great majority of patients can be managed successfully with medication. About 5-10% of patients require surgery for incapacitating vertigo
  • Very important not to overlook acoustic tumor, which produces an identical clinical picture

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Cochlear hydrops (hearing problem only)
  • Vestibular hydrops (balance problem only)
  • Drop attacks
AGE-RELATED FACTORS

Pediatric: Unusual, but occasional. Dizziness in children likely to be on basis of significant central nervous system disease.
Geriatric: Less likely to occur in elderly. Patients exposed to loud noise levels over many years are more susceptible.
Others: Usual onset age 20-60

PREGNANCY

Not a common problem, but difficult to treat because of risk of producing fetal abnormalities with medication

OTHER NOTES
  • Hearing loss
ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.